Antonia Clarissa Wehn

Dr. Antonia Clarissa Wehn

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 August 2021 in Acta Neuropathologica Communications
Verified
Journal Article
Open access
PDF file
AWAntonia Clarissa Wehn
Antonia Clarissa Wehn
IKIgor Khalin
Igor Khalin
MDMarco Duering
Marco Duering
FHFarida Hellal
Farida Hellal
Carsten CulmseeCarsten Culmsee
Carsten Culmsee
NTNicole Terpolilli
Nicole Terpolilli
Traumatic brain injury (TBI) causes acute and subacute tissue damage, but is also associated with chronic inflammation and progressive loss of brain tissue months and years after the initial event. The trigger and the subsequent molecular mechanisms causing chronic brain injury after TBI are not well understood. The aim of the current study was therefore to investigate the hypothesis that necroptosis, a form a programmed cell death mediated by the interaction of Receptor Interacting Protein Kinases (RIPK) 1 and 3, is involved in this process. Neuron-specific RIPK1- or RIPK3-deficient mice and their wild-type littermates were subjected to experimental TBI by controlled cortical impact. Posttraumatic brain damage and functional outcome were assessed longitudinally by repetitive magnetic resonance imaging (MRI) and behavioral tests (beam walk, Barnes maze, and tail suspension), respectively, for up to three months after injury. Thereafter, brains were investigated by immunohistochemistry for the necroptotic marker phosphorylated mixed lineage kinase like protein(pMLKL) and activation of astrocytes and microglia. WT mice showed progressive chronic brain damage in cortex and hippocampus and increased levels of pMLKL after TBI. Chronic brain damage occurred almost exclusively in areas with iron deposits and was significantly reduced in RIPK1- or RIPK3-deficient mice by up to 80%. Neuroprotection was accompanied by a reduction of astrocyte and microglia activation and improved memory function. The data of the current study suggest that progressive chronic brain damage and cognitive decline after TBI depend on the expression of RIPK1/3 in neurons. Hence, inhibition of necroptosis signaling may represent a novel therapeutic target for the prevention of chronic post-traumatic brain damage.

1 February 2024 in Journal of Neurotrauma
Verified
Journal Article
Closed access
SHSenbin Hu
Senbin Hu
CECarina Exner
Carina Exner
RSRebecca Isabella Sienel
Rebecca Isabella Sienel
AWAntonia Clarissa Wehn
Antonia Clarissa Wehn
BSBurcu Seker
Burcu Seker
SSSusanne M Schwarzmaier
Susanne M Schwarzmaier
Brain edema formation is a key factor for secondary tissue damage after traumatic brain injury (TBI). While vasogenic brain edema (VBE) is caused by blood brain barrier disruption, cytotoxic edema (CBE) is caused by astrocytic swelling. However, the type of brain edema and the time course of edema formation remain unclear. We performed free water imaging, a bi-tensor model based diffusion MRI analysis, to characterize VBE and CBE formation up to 7 days following experimental TBI. Male C57/Bl6 mice were subjected to Controlled Cortical Impact (CCI) or sham surgery and investigated by MRI 4 hours, 1, 2, 3, 5 and 7 days thereafter (n=8/group). We determined Mean Diffusivity (MD) and Free Water (FW) in contusion, peri-contusional area, ipsi- and contralateral brain tissue. Free, i.e. non-restricted, water was interpreted as VBE, restricted water as CBE. To verify the results, VBE formation was investigated by in-vivo 2-Photon Microscopy (2-PM) 48 hours after surgery. We found that MD and FW values decreased for 48 hours within the contusion, indicating the occurrence of CBE. In peri-contusional tissue MD and FW indices were increased at all time-points, suggesting the formation of VBE. This was consistent with our results obtained by 2-PM. Taken together, CBE formation occurs for 48 hours after trauma and is restricted to the contusion, while VBE forms in peri-contusional tissue up to 7 days after TBI. Our results indicate that free water MR imaging may represent a promising tool to investigate vasogenic and cytotoxic brain edema in the laboratory and in patients.

31 May 2024 in Journal of Controlled Release
Verified
Journal Article
Open access
AWAntonia Clarissa Wehn
Antonia Clarissa Wehn
EKEva Krestel
Eva Krestel
Biyan Nathanael HarapanBiyan Nathanael Harapan
Biyan Nathanael Harapan
AKAndrey Klymchenko
Andrey Klymchenko
NPNikolaus Plesnila
Nikolaus Plesnila
IKIgor Khalin
Igor Khalin
Nanoparticles have a great potential to significantly improve the delivery of therapeutics to the brain and may also be equipped with properties to investigate brain function. The brain, being a highly complex organ shielded by selective barriers, requires its own specialized detection system. However, a significant hurdle to achieve these goals is still the identification of individual nanoparticles within the brain with sufficient cellular, subcellular, and temporal resolution. This review aims to provide a comprehensive summary of the current knowledge on detection systems for tracking nanoparticles across the blood-brain barrier and within the brain. We discuss commonly employed in vivo and ex vivo nanoparticle identification and quantification methods, as well as various imaging modalities able to detect nanoparticles in the brain. Advantages and weaknesses of these modalities as well as the biological factors that must be considered when interpreting results obtained through nanotechnologies are summarized. Finally, we critically evaluate the prevailing limitations of existing technologies and explore potential solutions.

13 May 2021 in Journal of Neurotrauma
Verified
Journal Article
Closed access
SCShiqi Cheng
Shiqi Cheng
XMXiang Mao
Xiang Mao
XLXiangjiang Lin
Xiangjiang Lin
AWAntonia Clarissa Wehn
Antonia Clarissa Wehn
SHSenbin Hu
Senbin Hu
NTNicole Terpolilli
Nicole Terpolilli
Traumatic brain injury (TBI) causes long-lasting neurodegeneration and cognitive impairments; however, the underlying mechanisms of these processes are not fully understood. Acid-sensing ion channels 1a (ASIC1a) are voltage-gated Na + - and Ca 2+ -channels shown to be involved in neuronal cell death; however, their role for chronic post-traumatic brain damage is largely unknown. To address this issue, we used ASIC1a-deficient mice and investigated their outcome up to 6 months after TBI. ASIC1a-deficient mice and their wild-type (WT) littermates were subjected to controlled cortical impact (CCI) or sham surgery. Brain water content was analyzed 24 h and behavioral outcome up to 6 months after CCI. Lesion volume was assessed longitudinally by magnetic resonance imaging and 6 months after injury by histology. Brain water content was significantly reduced in ASIC1a –/– animals compared to WT controls. Over time, ASIC1a –/– mice showed significantly reduced lesion volume and reduced hippocampal damage. This translated into improved cognitive function and reduced depression-like behavior. Microglial activation was significantly reduced in ASIC1a –/– mice. In conclusion, ASIC1a deficiency resulted in reduced edema formation acutely after TBI and less brain damage, functional impairments, and neuroinflammation up to 6 months after injury. Hence, ASIC1a seems to be involved in chronic neurodegeneration after TBI.

15 November 2024 in Journal of Neurotrauma
Verified
Journal Article
Closed access
AWAntonia Clarissa Wehn
Antonia Clarissa Wehn
IKIgor Khalin
Igor Khalin
SHSenbin Hu
Senbin Hu
Biyan Nathanael HarapanBiyan Nathanael Harapan
Biyan Nathanael Harapan
XMXiang Mao
Xiang Mao
NTNicole Terpolilli
Nicole Terpolilli
The kallikrein–kinin system is one of the first inflammatory pathways to be activated following traumatic brain injury (TBI) and has been shown to exacerbate brain edema formation in the acute phase through activation of bradykinin 2 receptors (B2R). However, the influence of B2R on chronic post-traumatic damage and outcome is unclear. In the current study, we assessed long-term effects of B2R-knockout (KO) after experimental TBI. B2R KO mice (heterozygous, homozygous) and wild-type (WT) littermates ( n = 10/group) were subjected to controlled cortical impact (CCI) TBI. Lesion size was evaluated by magnetic resonance imaging up to 90 days after CCI. Motor and memory function were regularly assessed by Neurological Severity Score, Beam Walk, and Barnes maze test. Ninety days after TBI, brains were harvested for immunohistochemical analysis. There was no difference in cortical lesion size between B2R-deficient and WT animals 3 months after injury; however, hippocampal damage was reduced in B2R KO mice ( p = 0.03). Protection of hippocampal tissue was accompanied by a significant improvement of learning and memory function 3 months after TBI ( p = 0.02 WT vs. KO), whereas motor function was not influenced. Scar formation and astrogliosis were unaffected, but B2R deficiency led to a gene-dose-dependent attenuation of microglial activation and a reduction of CD45+ cells 3 months after TBI in cortex ( p = 0.0003) and hippocampus ( p < 0.0001). These results suggest that chronic hippocampal neurodegeneration and subsequent cognitive impairment are mediated by prolonged neuroinflammation and B2R. Inhibition of B2R may therefore represent a novel strategy to reduce long-term neurocognitive deficits after TBI.